Quality of Life Research

, Volume 24, Issue 1, pp 105–113 | Cite as

Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD

Quantitative Methods Special Section



Disease-specific patient-reported outcome (PRO) measures are designed to be highly relevant to one disease. It is widely believed that comparisons of outcomes between patients with different diseases are only possible using generic measures. The present study employs a novel method of using Rasch analysis to co-calibrate scores from different disease-specific PRO measures, allowing scores to be compared across diseases.


Psoriasis patients (n = 146, mean age = 44.4, males = 50 %) completed the Psoriasis Quality of Life scale (PSORIQoL) and atopic dermatitis patients (n = 146, mean age = 45.5, males = 50 %) the Quality of Life in Atopic Dermatitis scale (QoLIAD). Both measures employ the needs-based model of QoL, and they share five common items—providing a link between assessments. The groups were analysed separately, and then combined to test fit to the Rasch model.


Both scales showed good fit to the Rasch model after minor adjustments (PSORIQoL: χ 2 p = 0.25; QoLIAD: χ 2 p = 0.51). For the combined dataset, one common item showing differential item functioning by disease was removed and fit to the Rasch model was achieved (χ 2 p = 0.08). The co-calibrated scale successfully distinguished between perceived severity groups (p < 0.001).


It is possible to co-calibrate scores on the PSORIQoL and QoLIAD. This is one of the first studies in health research to demonstrate how Rasch analysis can be used to make comparisons across diseases using different disease-specific measures. Such an approach maintains the greater relevance and, consequently, accuracy associated with disease-specific measurement.


Psoriasis Atopic dermatitis PSORIQoL QoLIAD Rasch analysis Co-calibration Patient-reported outcomes Quality of life 



The study was unfunded. We thank the patients who completed the PSORIQoL and QoLIAD, Professor CEM Griffiths from Salford Royal Hospital and the UK National Eczema Society.


  1. 1.
    Otuki, M. F., Reis, R. C., Cabrini, D., Prudente, A. S., Horinouchi, C. D., & Correr, C. J. (2011). Patient-reported outcomes in psoriasis research and practice. British Journal of Dermatology, 165(6), 1361–1362.PubMedCrossRefGoogle Scholar
  2. 2.
    Rehal, B., & Armstrong, A. W. (2011). Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS One 13, 6(4), e17520.CrossRefGoogle Scholar
  3. 3.
    Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-Item Short-Form Health Survey (SF-36). Medical Care, 30, 474–483.Google Scholar
  4. 4.
    Hunt, S. M., McEwan, J., & McKenna, S. P. (1985). Measuring health status: a new tool for clinicians and epidemiologists. Journal of the Royal College of General Practitioners, 35(273), 185–188.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19, 210–216.PubMedCrossRefGoogle Scholar
  6. 6.
    Chren, M. M., Lasek, R. J., Flocke, S. A., & Zyzanski, S. J. (1997). Improved discriminative and evaluative capability of a refined version of Skindex, a quality of-life instrument for patients with skin diseases. Archives of Dermatology, 133, 1433–1440.PubMedCrossRefGoogle Scholar
  7. 7.
    McKenna, S. P., Cook, S. A., Whalley, D., Doward, L. C., Richards, H. L., Griffiths, C. E., et al. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology, 149, 323–331.PubMedCrossRefGoogle Scholar
  8. 8.
    Whalley, D., McKenna, S. P., Dewar, A. L., Erdman, R. A., Kohlmann, T., Niero, M., et al. (2004). A new instrument for assessing Quality of Life in Atopic Dermatitis (QoLIAD). British Journal of Dermatology, 150, 274–283.PubMedCrossRefGoogle Scholar
  9. 9.
    Nijsten, T. E., Sampogna, F., Chren, M. M., & Abeni, D. D. (2006). Testing and reducing skindex-29 using Rasch analysis: Skindex-17. Journal of Investigative Dermatology, 126, 1244–1250.PubMedCrossRefGoogle Scholar
  10. 10.
    Nijsten, T. E., Meads, D. M., de Korte, J., Sampogna, F., Gelfand, J. M., Ongenae, K., et al. (2007). Cross-cultural inequivalence of dermatology-specific health related quality of life instruments in psoriasis patients. Journal of Investigative Dermatology, 127, 2315–2322.PubMedCrossRefGoogle Scholar
  11. 11.
    Both, H., Essink-Bot, M. L., Busschbach, J., & Nijsten, T. (2007). Critical review of generic and dermatology-specific health-related quality of life instruments. Journal of Investigative Dermatology, 127, 2726–2739.PubMedCrossRefGoogle Scholar
  12. 12.
    Twiss, J., Meads, D. M., Preston, E. P., Crawford, S. R., & McKenna, S. P. (2012). Can we rely on the Dermatology Life Quality Index (DLQI) as a measure of the impact of psoriasis or atopic dermatitis? Journal of Investigative Dermatology, 132(1), 76–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Prinsen, C. A., de Korte, J., Augustin, M., Sampogna, F., Salek, S. S., & Basra, M. K., et al. (2013). Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. Journal of the European Academy of Dermatology and Venereology, 27(10), 1195–203.Google Scholar
  14. 14.
    Chamlin, S. L., & Chren, M. M. (2010). Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunology and Allergy Clinics of North America, 30(3), 281–288.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    McKenna, S. P. (2011). Measuring patient-reported outcomes: Moving beyond misplaced common sense to hard science. BMC Medicine, 9, 86.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Potocka, A., Turczyn-Jabłońska, K., & Kieć-Swierczyńska, M. (2008). Self-image and quality of life of dermatology patients. International Journal of Occupational Medicine and Environmental Health, 21(4), 309–317.PubMedCrossRefGoogle Scholar
  17. 17.
    Potocka, A., Turczyn-Jabloñska, K., & Merecz, D. (2009). Psychological correlates of quality of life in dermatology patients: The role of mental health and self-acceptance. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 18(2), 53–58.Google Scholar
  18. 18.
    Ludwig, M. W., Oliveira Mda, S., Muller, M. C., & Moraes, J. F. (2009). Quality of life and site of the lesion in dermatological patients. Anais Brasileiros de Dermatologia, 84(2), 143–150.PubMedCrossRefGoogle Scholar
  19. 19.
    Quandt, S. A., Schulz, M. R., Vallejos, Q. M., Feldman, S. R., Verma, A., Fleischer, A. B., et al. (2008). The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers. International Journal of Dermatology, 47(3), 236–241.PubMedCrossRefGoogle Scholar
  20. 20.
    Papoutsaki, M., Chimenti, M. S., Costanzo, A., Talamonti, M., Zangrilli, A., Giunta, A., et al. (2007). Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics. Journal of the American Academy of Dermatology, 57(2), 269–275.PubMedCrossRefGoogle Scholar
  21. 21.
    Schmitt, J., Heese, E., Wozel, G., & Meurer, M. (2007). Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris: A prospective study. Dermatology, 214(1), 68–76.PubMedCrossRefGoogle Scholar
  22. 22.
    Dallmeijer, A. J., de Groot, V., Roorda, L. D., Schepers, V. P., Lindeman, E., van den Berg, L. H., et al. (2007). Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: A study using Rasch analysis. Journal of Rehabilitation Medicine, 39(2), 163–169.PubMedCrossRefGoogle Scholar
  23. 23.
    Taylor, W. J., & McPherson, K. M. (2007). Using Rasch analysis to compare the psychometric properties of the short form 36 physical function score and the health assessment questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis. Arthritis & Rheumatism (Arthritis Care & Research), 57(5), 723–729.CrossRefGoogle Scholar
  24. 24.
    Jenkinson, C., Fitzpatrick, R., Garratt, A., Peto, V., & Stewart-Brown, S. (2001). Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10). Journal of Neurology, Neurosurgery and Psychiatry, 71, 220–224.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Velanovich, V. (1998). Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. Journal of Gastrointestinal Surgery, 2(2), 141–145.PubMedCrossRefGoogle Scholar
  26. 26.
    Shikiar, R., Willian, M. K., Okun, M. M., Thompson, C. S., & Revicki, D. A. (2006). The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health and Quality of Life Outcomes, 27(4), 71.CrossRefGoogle Scholar
  27. 27.
    Angst, F., Verra, M. L., Lehmann, S., & Aeschlimann, A. (2008). Responsiveness of five condition-specific and generic outcome assessment instruments for chronic pain. BMC Medical Resesearch Methodology, 25(8), 26.CrossRefGoogle Scholar
  28. 28.
    Dawson, J., Boller, I., Doll, H., Lavis, G., Sharp, R., Cooke, P., et al. (2012). Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. The Journal of Bone and Joint Surgery, 94(2), 215–221.PubMedCrossRefGoogle Scholar
  29. 29.
    Jull, A., Parag, V., Walker, N., & Rodgers, A. (2010). Responsiveness of generic and disease-specific health-related quality of life instruments to venous ulcer healing. Wound Repair and Regeneration, 18(1), 26–30.PubMedCrossRefGoogle Scholar
  30. 30.
    Reeve, B. B., Hays, R. D., Chang, C., & Perfetto, E. M. (2007). Applying item response theory to enhance health outcomes assessment. Quality of Life Research, 16, 1–3.CrossRefGoogle Scholar
  31. 31.
    Hunt, S. M., & McKenna, S. P. (1992). The QLDS: A scale for the measurement of quality of life in depression. Health Policy, 22, 307–319.PubMedCrossRefGoogle Scholar
  32. 32.
    Maslow, A. H. (1970). Motivation and personality (2nd ed.). New York: Harper & Row.Google Scholar
  33. 33.
    Max-Neef, M. A., Elizalde, A., & Hopenhayn, M. (1991). Human scale development: conception application and further reflections (p. 18). New York: Apex Press.Google Scholar
  34. 34.
    Kenrick, D. T., Griskevicius, V., Neuberg, S. L., & Schaller, M. (2010). Renovating the pyramid of needs: Contemporary extensions built upon ancient foundations. Perspectives on psychological science, 5, 292.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Rasch, G. (1960). (Reprinted 1980). Probabilistic Models for Some Intelligence and Attainment Tests.. Chicago: University of Chicago Press.Google Scholar
  36. 36.
    Tennant, A., McKenna, S. P., & Hagell, P. (2004). Application of Rasch analysis in the development and application of quality of life instruments. Value in Health, 7(Suppl 1), S22–S26.PubMedCrossRefGoogle Scholar
  37. 37.
    Tennant, A., & Gonaghan, P. G. (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one should one look for in a Rasch paper? Arthritis and Rheumatism, 57, 1358–1362.PubMedCrossRefGoogle Scholar
  38. 38.
    Holland, P. W., & Wainer, H. (Eds.). (1993). Differential item functioning. New Jersey: Lawrence Erlbaum Associates.Google Scholar
  39. 39.
    Smith, E. V. (2002). Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. Journal of Applied Measurement, 3(2), 205–231.PubMedGoogle Scholar
  40. 40.
    Andrich, D. (1988). Rasch models for measurement., Sage University paper series on Quality Application in the social sciences Sage Publications Inc: Newbury Park.Google Scholar
  41. 41.
    Andrich, D., Sheridan, B., & Luo, G. (2009). Interpretting RUMM2030 (4TH ed.). Perth: RUMM Laboratory Pty Ltd.Google Scholar
  42. 42.
    Latimer, S., et al. (2012). Co-calibration of deliberate self harm (DSH) behaviours: towards a common measurement metric. Psychiatry Research, 200(1), 26–34.PubMedCrossRefGoogle Scholar
  43. 43.
    Thissen, D., Varni, J. W., Stucky, B. D., Liu, Y., Irwin, D. E., & DeWalt, D. A. (2011). Using the PedsQL™ 3.0 Asthma Module to obtain scores comparable with those of the PROMIS Pediatric Asthma Impact Scale (PAIS). Quality of Life Research, 20, 1497–1505.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Crane, P. K., Narasimhalu, K., Gibbons, L. E., Mungas, D. M., Haneuse, S., Larson, E. B., et al. (2008). Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. Journal of Clinical Epidemiology, 61(10), 1018–1027.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Chalkidou, K. & Anderson, G. (2009). Comparative effectiveness research: international experiences and implications for the United States. http://www.academyhealth.org/files/publications/CER_International_Experience_09%20(3).pdf September, 2013.
  46. 46.
    McKenna, S. P., Meads, D. M., Doward, L. C., Twiss, J., Pokrzywinski, R., Revicki, D., et al. (2011). Development and validation of the living with chronic obstructive pulmonary disease questionnaire. Quality of Life Research, 20, 1043–1052.PubMedCrossRefGoogle Scholar
  47. 47.
    Doward, L. C., McKenna, S. P., Meads, D. M., Twiss, J., & Eckert, B. J. (2009). The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Multiple Sclerosis, 15, 1092–1102.PubMedCrossRefGoogle Scholar
  48. 48.
    Keenan, A. M., Mckenna, S. P., Doward, L. C., Conaghan, P. G., Emery, P., & Tennant, A. (2008). Development and validation of a needs-based quality of life instrument for osteoarthritis. Arthritis & Rheumatism (Arthritis Care & Research), 59(6), 841–848.CrossRefGoogle Scholar
  49. 49.
    McKenna, S. P., Doughty, N., Meads, D. M., Doward, L. C., & Pepke-Zaba, J. (2006). The Cambridge pulmonary hypertension outcome review (CAMPHOR): A measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Quality of Life Research, 15(103–115), 54.Google Scholar
  50. 50.
    Haley, S. M., Ni, P., Lai, J. S., Tian, F., Coster, W. J., Jette, A. M., et al. (2011). Linking the activity measure for post acute care and the quality of life outcomes in neurological disorders. Archives of Physical Medicine and Rehabilitation, 92, S37–S43.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    McHorney, C. A. (2002). Use of item response theory to link 3 modules of functional status items from the asset and health dynamics among the oldest old study. Archives of Physical Medicine and Rehabilitation, 83(3), 383–394.PubMedCrossRefGoogle Scholar
  52. 52.
    Thissen, D., Varni, J. W., Stucky, B. D., Liu, Y., Irwin, D. E., & DeWalt, D. A. (2011). Using the PedsQL 3.0 asthma module to obtain scores comparable with those of the PROMIS pediatric asthma impact scale (PAIS). Quality of Life Research, 20(9), 1497–1505.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Vale, C. D. (1986). Linking item parameters onto a common scale. Applied Psychological Measurement, 10, 333–344.CrossRefGoogle Scholar
  54. 54.
    Wolfe, E. W. (2000). Equating and item banking with the Rasch model. Journal of Applied Measurement, 1(4), 409–434.PubMedGoogle Scholar
  55. 55.
    Angoff, W.H. Scales, norming, and equivalent scores. In R. L. Thorndike (Ed.), Education measurement (2nd ed., pp. 508–600). Washington, DC: American Council on Education.Google Scholar
  56. 56.
    Wingersky, M. S., & Lord, F. M. (1984). An investigation of methods for reducing sampling error in certain IRT procedures. Applied Psychological Measurement, 8, 347–364.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Galen Research Ltd, Enterprise HouseManchester Science ParkManchesterUK

Personalised recommendations